Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Interaction Map Rank Network Comparison Type red Gene green Filtered network_comparison
Results: HTML CSV LaTeX
Showing element 1030 to 1079 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fibrillarin (34 kda nucleolar scleroderma antigen). [source:swissprot;acc:p22087]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
646\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4019.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4522.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12506\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fibrillin 1 precursor. [source:swissprot;acc:p35555]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2844\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fibrillin 2 precursor. [source:swissprot;acc:p35556]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2955\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fibrillin 3. [source:refseq;acc:nm\_032447]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2939\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fibulin-1 precursor. [source:swissprot;acc:p23142]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1304\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8550.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9248.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08154\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fibulin-2 precursor. [source:swissprot;acc:p98095]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1216\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8670.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9412.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08561\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
21\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fidgetin-like 1. [source:refseq;acc:nm\_022116]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1491\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6057.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6510.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07486\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
filamin a (alpha-filamin) (filamin 1) (endothelial actin-binding protein) (abp-280) (nonmuscle filamin). [source:swissprot;acc:p21333]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
113\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4366.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5899.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.35116\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
filamin b, beta (actin binding protein 278); beta filamin; filamin 1 (actin-binding protein-280)-like; filamin b, beta (actin-binding protein-278); filamin b, beta. [source:refseq;acc:nm\_001457]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
108\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fip1-like 1; rearranged in hypereosinophilia. [source:refseq;acc:nm\_030917]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
270\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23640.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19479.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21358\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fk506-binding protein 1a (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (12 kda fkbp) (fkbp-12) (immunophilin fkbp12). [source:swissprot;acc:p20071]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1207\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5946.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6459.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08635\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
flap endonuclease-1 (ec 3.-.-.-) (maturation factor 1) (mf1). [source:swissprot;acc:p39748]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2831\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
556\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13615\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
flotillin-1. [source:swissprot;acc:o75955]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1296\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08218\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
folylpolyglutamate synthase, mitochondrial precursor (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs). [source:swissprot;acc:q05932]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2009\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4934.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5223.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05861\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
forkhead box p4; fork head-related protein like a; winged-helix repressor foxp4. [source:refseq;acc:nm\_138457]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
130\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2234.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2978.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33287\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
forkhead box protein g1c (forkhead-related protein fkhl3) (hfk3) (fragment). [source:swissprot;acc:q14488]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
578\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6739.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7644.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
forkhead box protein p1 (hspc215). [source:swissprot;acc:q9h334]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
131\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2234.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2978.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33285\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
forkhead box protein p3 (zinc finger protein jm2) (scurfin). [source:swissprot;acc:q9bzs1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
132\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2236.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2980.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33253\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
formin binding protein 3; fas-ligand associated factor 1; huntingtin-interacting protein a; ny-ren-6 antigen. [source:refseq;acc:nm\_017892]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
93\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4245.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5942.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.39977\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
87\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4944.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7038.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
85\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4941.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7037.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42395\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation 1 protein (protein fmr-1) (fmrp). [source:swissprot;acc:q06787]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2431\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7242.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7508.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03676\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 1. [source:swissprot;acc:p51114]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2429\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7243.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7509.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03681\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 2. [source:swissprot;acc:p51116]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2428\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
frg1 protein (fshd region gene 1 protein). [source:swissprot;acc:q14331]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1926\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7260.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06213\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1036\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6077.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6649.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09404\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1033\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6080.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6653.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09417\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase a (ec 4.1.2.13) (muscle-type aldolase) (lung cancer antigen ny-lu-1). [source:swissprot;acc:p04075]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2907\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase b (ec 4.1.2.13) (liver-type aldolase). [source:swissprot;acc:p05062]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2973\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase c (ec 4.1.2.13) (brain-type aldolase). [source:swissprot;acc:p09972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3087\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ftsj homolog 3; likely ortholog of mouse ectoplacental cone, invasive trophoblast giant cells, extraembryonic ectoderm and chorion sequence 3. [source:refseq;acc:nm\_017647]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
621\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4115.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4633.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12601\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fumarate hydratase, mitochondrial precursor (ec 4.2.1.2) (fumarase). [source:swissprot;acc:p07954]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2726\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5332.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5351.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fuse binding protein 3 (fragment). [source:sptrembl;acc:q92946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2093\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5817.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6138.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05524\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fuse-binding protein-interacting repressor isoform b; siah binding protein 1; pyrimidine tract binding splicing factor; ro ribonucleoprotein-binding protein 1; poly-u binding splicing factor puf60. [source:refseq;acc:nm\_014281]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1590\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6364.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6819.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07155\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1820\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fyve-finger-containing rab5 effector protein rabenosyn-5. [source:refseq;acc:nm\_022340]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2998\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fzr1 protein; fizzy-related protein; cdc20-like 1b. [source:refseq;acc:nm\_016263]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
733\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13241.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11864\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1161\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g protein-coupled receptor 66. [source:refseq;acc:nm\_006056]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2815\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g-rich sequence factor-1 (grsf-1). [source:swissprot;acc:q12849]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1396\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07806\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1336\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6140.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6632.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b1. [source:swissprot;acc:p14635]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12786.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10879.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17525\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
360\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12796.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10886\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ga binding protein alpha chain (gabp-alpha subunit) (transcription factor e4tf1-60) (nuclear respiratory factor-2 subunit alpha). [source:swissprot;acc:q06546]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
455\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ga binding protein beta-2 chain (gabp-beta-2 subunit) (transcription factor e4tf1-47) (gapbp-2) (nuclear respiratory factor-2 subunit gamma). [source:swissprot;acc:q06545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
456\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23421.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17580.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33225\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
134\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.32626\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galactose-1-phosphate uridylyltransferase (ec 2.7.7.12) (gal-1-p uridylyltransferase) (udp-glucose--hexose-1-phosphate uridylyltransferase). [source:swissprot;acc:p07902]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
517\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4910.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5600.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14051\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
966\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7817.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8575.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09686\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/